Least likely to cause cardiac failure:
  ?     propranolol (Inderal)  ?     pindolol (Visken)  ?     metoprolol (Lopressor)Major adverse effects of verapamil (Isoptin, Calan) or diltiazem (Cardiazem) IV administration:
  ?     diarrhea  ?     hypotension  ?     positive inotropism  ?     strokeSame antiarrhythmic classification: disopyramide (Norpace) and
  ?     propranolol (Inderal)  ?     triamterene (Dyrenium)  ?     procainamide (Procan SR, Pronestyl-SR)  ?     bretylium (Bretylol)  ?     diltiazem (Cardiazem)Most likely effective in treating supraventricular tachyarrhythmias:
  ?     flecainide (Tambocor)  ?     esmolol (Brevibloc)  ?     lidocaine (Xylocaine)  ?     hydroxyzine (Atarax,Vistaril)  ?     atropineA reversible lupus erythematous-like syndrome is most likely associated with this antiarrhythmic drug.
  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     adenosine (Adenocard)  ?     carbamazepine (Tegretol)  ?     procainamide (Procan SR, Pronestyl-SR)  ?     lidocaine (Xylocaine)Antiarrhythmic drug most likely to cause seizures (at high concentrations) by direct CNS actions:
  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     amiodarone (Cordarone)  ?     lidocaine (Xylocaine)  ?     phenytoin (Dilantin)  ?     propranolol (Inderal)Antiarrhythmic drug, acting at potassium channels:
  ?     adenosine (Adenocard)  ?     sotalol (Betapace)  ?     diltiazem (Cardiazem)  ?     esmolol (Brevibloc)  ?     quinidine gluconate (Quinaglute, Quinalan)Cinchonism: adverse effect associated with this antiarrhythmic drug.
  ?     procainamide (Procan SR, Pronestyl-SR)  ?     verapamil (Isoptin, Calan)  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     flecainide (Tambocor)  ?     adenosine (Adenocard)Antiarrhythmic drug, administered IV, typically used to suppress ventricular arrhythmias associated with acute myocardial infarction:
  ?     amiodarone (Cordarone)  ?     metoprolol (Lopressor)  ?     lidocaine (Xylocaine)  ?     phenytoin (Dilantin)  ?     esmolol (Brevibloc)Despite being a myocardial depressant, this antiarrhythmic drug's anticholinergic properties facilitate AV nodal transmission:
  ?     phenytoin (Dilantin)  ?     amiodarone (Cordarone)  ?     adenosine (Adenocard)  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     diltiazem (Cardiazem)Changes in cardiac automaticity is most directly associated with changes in which slope of the myocardial action potential?
  ?     phase 0  ?     phase 1  ?     phase 2  ?     phase 3  ?     phase 4Contraindicated in asthmatic patients, this antiarrhythmic drug blocks beta-1 receptors.
  ?     adenosine (Adenocard)  ?     lidocaine (Xylocaine)  ?     procainamide (Procan SR, Pronestyl-SR)  ?     propranolol (Inderal)  ?     none of the aboveClass II antiarrhythmic drug
  ?     adenosine (Adenocard)  ?     atropine  ?     esmolol (Brevibloc)  ?     lidocaine (Xylocaine)  ?     mexiletine (Mexitil)Muscarinic receptor antagonist, this antiarrhythmic drug may be effective in managing bradycardia.
  ?     esmolol (Brevibloc)  ?     adenosine (Adenocard)  ?      lidocaine (Xylocaine)  ?     atropine  ?     mexiletine (Mexitil)Calcium channel blocker -- effective in treating supraventricular arrhythmias:
  ?     tocainide (Tonocard)  ?     verapamil (Isoptin, Calan)  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     procainamide (Procan SR, Pronestyl-SR)  ?     heparinClass III antiarrhythmic drug may be effective in treating ventricular arrhythmias; prolongs phase 3 (repolarization); potassium channel blocker
  ?     esmolol (Brevibloc)  ?     amiodarone (Cordarone)  ?     lidocaine (Xylocaine)  ?     propafenone (Rythmol)  ?     moricizine (Ethmozine)Naturally occurring metabolites, given by IV administration, this antiarrhythmic agent slows conduction through the AV node
  ?     esmolol (Brevibloc)  ?     adenosine (Adenocard)  ?     lidocaine (Xylocaine)  ?     procainamide (Procan SR, Pronestyl-SR)  ?     bretylium (Bretylol)Digoxin (Lanoxin, Lanoxicaps) is useful in treating high ventricular rates in patients with atrial fibrillation because:
  ?     digoxin (Lanoxin, Lanoxicaps) is a good drug for stopping atrial fibrillation  ?     digoxin (Lanoxin, Lanoxicaps) increases cardiac contractility  ?     digoxin (Lanoxin, Lanoxicaps) slows conduction through the AV node; therefore it reduces heart rate  ?     digoxin (Lanoxin, Lanoxicaps) is metabolized in the liver  ?     digoxin (Lanoxin, Lanoxicaps) is inexpensiveAntiarrhythmic drug likely to increase heart rate:
  ?     tocainide (Tonocard)  ?     verapamil (Isoptin, Calan)  ?     quinidine gluconate (Quinaglute, Quinalan)  ?     propranolol (Inderal)  ?     esmolol (Brevibloc)Always administered by IV because of significant first-pass effect, this anti-rhythmic drug suppresses ventricular arrhythmias associated with acute myocardial infarction; CNS side effects are prominent in overdosage.
  ?     verapamil (Isoptin, Calan)  ?     propranolol (Inderal)  ?     lidocaine (Xylocaine)  ?     amiodarone (Cordarone)  ?     quinidine gluconate (Quinaglute, Quinalan)